Remix Therapeutics

Our Science
- Platform
- Pipeline
About Us
Join Us
News
Clinical Trials

Our Science
- Platform
- Pipeline
About Us
Join Us
News
Clinical Trials
Contact

Advisor Category: Advisors

Ryan Corcoran

Benoit Chabot

Serena Hung

James Summers

Rui Zhao

Juan Valcarcel

Will Fairbrother

Phillip Wong

Aaron Gitler

Daniela Zarnescu

Posts navigation

Search

Recent Posts

Remix Therapeutics™ Appoints Linda C. Bain to Board of Directors
Remix Therapeutics™ to Present at Stifel 2025 Virtual Targeted Oncology Forum
REM-422, a First-in-Class mRNA Degrader of the MYB Oncogene, Demonstrates Anti-tumor Activity in Xenograft Models of Adenoid Cystic Carcinoma and Acute Myeloid Leukemia
Remix Therapeutics™ Announces Participation in Leerink Global Healthcare Conference
Reprogramming RNA processing: an emerging therapeutic landscape

Recent Comments

No comments to show.

Archives

April 2025
March 2025
February 2025
January 2025
November 2024
October 2024
September 2024
August 2024
July 2024
June 2024
May 2024
February 2024
January 2024
December 2023
September 2023
May 2023
March 2023
January 2023
December 2022
September 2022
May 2022
March 2022
February 2022
January 2022
December 2021
August 2021
March 2021
January 2021
December 2020

Categories

News
Press Release
Publication

Remix Therapeutics

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

Our Science
About Us
Join Us
News
Clinical Trials
Contact

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

© 2023 Remix Therapeutics, Inc. All Rights Reserved